GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY

被引：0

作者：

Sever, M. Jensterle ^{[1
,2
]}

机构：

[1] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana, Slovenia

[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

230

引用

页码：A6 / A6

页数：1

共 50 条

[41] The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity
Friedman, Jeffrey M.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (39)
[42] TREATMENT OF OBESITY IN GP'S OFFICE USING GLP-1 AGONIST LIRAGLUTIDE
Lastovkova, Andrea
ATHEROSCLEROSIS, 2024, 399
[43] Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus
Vilsboll, Tina
Knop, Filip K.
BIODRUGS, 2008, 22 (04) : 251 - 257
[44] Long-Acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus
Tina Vilsbøll
Filip K Knop
BioDrugs, 2008, 22 : 251 - 257
[45] GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
Li, Ying
Zheng, Xuemin
Tang, Lida
Xu, Weiren
Gong, Min
PEPTIDES, 2011, 32 (06) : 1303 - 1312
[46] Impaired Satiety Effect of GLP-1 Agonist in Obesity Is Associated With GLP-1 Resistance in Intestinal Afferent Nerves
Al-Helaili, Alaa
Wang, Beini
Beyak, Michael
GASTROENTEROLOGY, 2014, 146 (05) : S842 - S842
[47] GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Pourkarim, Fariba
Entezari-Maleki, Taher
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2303 - 2304
[48] Winning researchers unlocked GLP-1 drugs for obesity
Phelan, Meagan
SCIENCE, 2024, 384 (6699) : 968 - 970
[49] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
Gallwitz, B.
DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
[50] Therapies for inter-relating diabetes and obesity - GLP-1 and obesity
Iepsen, Eva W.
Torekov, Signe S.
Holst, Jens J.
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2487 - 2500

← 1 2 3 4 5 →